| Date | Time | Source | Headline | Symbol | Company |
| 11/09/2021 | 4:05PM | PR Newswire (US) | INOVIO Reports Third Quarter 2021 Financial Results | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 11/09/2021 | 8:00AM | PR Newswire (US) | INOVIO Receives U.S. FDA Authorization to Proceed with INNOVATE Phase 3 Segment for its COVID-19 Vaccine Candidate, INO-4800, in the U.S. | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 11/05/2021 | 8:00AM | PR Newswire (US) | INOVIO Expands Executive Leadership to Prepare for Commercial Operations | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 11/03/2021 | 8:00AM | PR Newswire (US) | INOVIO Further Expands INNOVATE Phase 3 Trial for COVID-19 DNA Vaccine Candidate INO-4800 With Regulatory Authorization from India | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 10/29/2021 | 5:02PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 10/28/2021 | 6:11AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 10/27/2021 | 8:00AM | PR Newswire (US) | INOVIO to Report Third Quarter 2021 Financial Results on November 9, 2021 | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 10/26/2021 | 8:00AM | PR Newswire (US) | INOVIO Completes Enrollment of Phase 1B Clinical Trial for its DNA Vaccine Candidate Against Lassa Fever, INO-4500, in West Africa | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 10/21/2021 | 8:00AM | PR Newswire (US) | INOVIO Announces Collaboration with Colombia; Memorandum of Understanding Focuses on Protecting Against COVID-19 and Supporting Broader Health Preparedness Initiatives | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 10/12/2021 | 8:00AM | PR Newswire (US) | INOVIO Announces Online Preprint Publication of Homologous Boosting Data for its COVID-19 DNA Vaccine Candidate, INO-4800 | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 10/11/2021 | 8:00AM | PR Newswire (US) | INOVIO Expands INNOVATE Phase 3 for INO-4800, its DNA Vaccine Candidate for COVID-19, to include Colombia following Regulatory Authorization | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 09/29/2021 | 8:00AM | PR Newswire (US) | INOVIO to Present Three Posters at IDWeek 2021 | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 09/22/2021 | 8:00AM | PR Newswire (US) | INOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800, in Mexico | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 09/01/2021 | 8:00AM | PR Newswire (US) | INOVIO to Present at Upcoming Investor Conferences in September | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 08/26/2021 | 8:00AM | PR Newswire (US) | INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800 | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 08/12/2021 | 8:41AM | TipRanks | Inovio: Covid-19 Vaccine Opportunity Still at Play | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 08/11/2021 | 4:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 08/10/2021 | 8:30AM | TipRanks | Inovio Pharmaceuticals’ Q2 Results Miss Estimates; Shares Dip 4.2% Pre-Market | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 08/09/2021 | 4:05PM | PR Newswire (US) | INOVIO Reports Second Quarter 2021 Financial Results | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 08/09/2021 | 4:02PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 08/09/2021 | 8:00AM | PR Newswire (US) | INOVIO and Advaccine Receive Regulatory Allowance for Two Heterologous Prime-Boost Clinical Trials in China Using INO-4800, INOVIO's COVID-19 DNA Vaccine Candidate | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 08/04/2021 | 8:00AM | PR Newswire (US) | INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), a Coronavirus Disease | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 07/26/2021 | 8:00AM | PR Newswire (US) | INOVIO to Report Second Quarter 2021 Financial Results on August 9, 2021 | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 06/30/2021 | 4:12PM | TipRanks | Inovio Has a Great Pipeline — But Is Its Stock a Buy? | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 06/11/2021 | 4:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 06/11/2021 | 4:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 06/11/2021 | 4:25PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 06/11/2021 | 4:02PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 06/08/2021 | 8:00AM | PR Newswire (US) | INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate, INO-480... | NASDAQ:INO | Inovio Pharmaceuticals Inc New |
| 06/03/2021 | 8:00AM | PR Newswire (US) | Geneos Therapeutics Announces Clinical Updates on Personalized Cancer Vaccine Program | NASDAQ:INO | Inovio Pharmaceuticals Inc New |